Sanofi-Aventis related Press Releases
Early Communication About Safety of Lantus (insulin glargine)
Early Communication About Safety of Lantus (insulin glargine) 7/1/2009 FDA is aware of four recently-published observational studies that looked at the use of Lantus (insulin glargine) and possible... Read more...
Sanofi-aventis Stands Behind the Safety of Lantus
Sanofi-aventis Stands Behind the Safety of Lantus(R) BRIDGEWATER, N.J., June 26 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has just been made aware of data associated with... Read more...
Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations
Aventis Pharmaceutical to Pay U.S. $95.5 Million to Settle False Claims Act Allegations WASHINGTON - Aventis Pharmaceutical Inc., a wholly owned subsidiary of sanofi-aventis U.S. LLC, has agreed to... Read more...
Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation
Sanofi-aventis U.S. Announces Settlement of Medicaid 'Best Price' Investigation By: PR Newswire | 28 May 2009 | 11:12 AM ET Text Size BRIDGEWATER, N.J., May 28, 2009 /PRNewswire-FirstCall via COMTEX/... Read more...
FDA warning letter to Sanofi-Aventis re Taxotere marketing
TRANSMITTED BY FACSIMILE MaryRose Salvacion Director, US Regulatory Affairs Marketed Products sanofi-aventis P.O. Box 5925, 55 Corporate Drive Bridgewater, NJ 08807 RE: NDA #20-449 Taxotere®... Read more...
Antisoma sells oral fludarabine to sanofi-aventis U.S. for USD 65 million
Antisoma sells oral fludarabine to sanofi-aventis U.S. for USD 65 million London, UK, and Cambridge, MA: 12 May 2009 - Antisoma plc (LSE: ASM; US OTC: ATSMY) today announces that it has sold the US
... Read more...Sanofi-Aventis Builds New Manufacturing Base in Hangzhou
Sanofi-Aventis Builds New Manufacturing Base in Hangzhou HANGZHOU, China - April 21, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the company will relocate its current
... Read more...Sanofi-Aventis Acquires Laboratorios Kendrick in Mexico
Sanofi-aventis Acquires Laboratorios Kendrick in Mexico - Acquisition Advances Emerging Markets Strategy - Paris, France - April 2, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced
... Read more...Jérôme Contamine appointed Chief Financial Officer
Jérôme Contamine appointed Chief Financial Officer PARIS, March 9, 2009 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that Jérôme Contamine is appointed
... Read more...AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prost
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia All amounts are in US dollars QUEBEC CITY, March 6
... Read more...Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
